✦ LIBER ✦

Potential Clinical Utility of Advanced Glycation End Product Cross-Link Breakers in Age- and Diabetes-Associated Disorders

✍ Scribed by Yamagishi, Sho-ichi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1P-0273 Attenuation of diabetes-associat

✍ Calkin, A.C.; Yee, L.T.L.; Thallas, V.; Jandeleit-Dahm, K.; Thomas, M.C.; Founds 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Effects of advanced glycation end-produc

✍ Peter S. Oturai; Mogens Christensen; Bidda Rolin; Kent E. Pedersen; Steen B. Mor 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 58 KB

W13-P-026 The potential role of advanced

✍ Yoon, Y.W.; Kwon, H.M.; Hwang, K.C.; Choi, E.Y.; Hong, B.K.; Kim, D.S.; Kim, H.S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Investigations on the correlation of adv

✍ V. Renju Gopal; M. Indira 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Attenuating effects of Ganoderma lucidum

✍ Guoliang Meng; Hongyan Zhu; Shengju Yang; Feng Wu; Huihua Zheng; E Chen; Jiliang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Serum levels of soluble form of receptor

✍ Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Takanori Matsui; Yayoi Kurit 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 149 KB